Identifying Risk Factors Associated With Meningioma: A Systematic Review
Author(s)
Vyshnavi Telukuntla, Pharm D, Sumi Pillai, Pharm D, Nidhun Kandoth, M.Pharm, Sukannya Mahapatra, M.Pharm, Ankit Rohilla, M.Pharm, Inderpreet Singh Khurana, M.Pharm.
Lumanity, Gurugram, India.
Lumanity, Gurugram, India.
OBJECTIVES: Meningiomas are the most common intracranial tumours in adults, typically slow growing. This review aims to identify and evaluate risk factors associated with meningioma development in adults.
METHODS: A systematic search was conducted in Embase® and MEDLINE® via Embase.com for English-language articles reporting risk factors in patients with meningioma.
RESULTS: Of 1,216 records screened, 58 studies were included. Older age (≥ 65 years) increased risk (odds ratio [OR] = 1.65; 95% confidence interval [CI]: 1.03, 2.65). Female sex was strongly associated with higher incidence, up to 3.4 times greater than in males. Obesity (BMI ≥ 30) increased risk, relative risk [RR] of 1.40 (95% CI: 1.08, 1.87), and each 5 kg/m² increase raised risk by 5% (hazard ration [HR] = 1.05; 95% CI: 1.00, 1.10). Height per 10 cm increase was associated with higher risk in both women, HR = 1.38 (95% CI: 1.08, 1.77) and men HR = 1.67 (95% CI: 0.93, 2.97). Occupational exposure to iron was associated with a borderline significant increase in meningioma risk (OR = 1.26; 95% CI: 1.00, 1.58), with a stronger and statistically significant association in women (OR = 1.70; 95% CI: 1.00, 2.89). Additionally, higher occupational exposures to chromium and nickel were linked to an increase in risk, with ORs ranging from 1.2-1.7. Hormonal exposures including chlormadinone acetate (RR = 3.1), cyproterone acetate (RR = 11.4) and fertility treatments (OR = 4.97) were significantly increased risk. Analgesic use was also implicated: aspirin (OR = 1.41) and acetaminophen (OR = 1.85). Brain radiation exposure showed a clear dose-dependent risk increase (excess RR/1 Gy = 1.82), suggesting a strong linear relationship.
CONCLUSIONS: Meningioma risk is influenced by age, gender, BMI, height, hormonal therapies, analgesics, and occupational exposure to metals and radiation, highlighting the complex interplay of biological, environmental, and lifestyle factors.
METHODS: A systematic search was conducted in Embase® and MEDLINE® via Embase.com for English-language articles reporting risk factors in patients with meningioma.
RESULTS: Of 1,216 records screened, 58 studies were included. Older age (≥ 65 years) increased risk (odds ratio [OR] = 1.65; 95% confidence interval [CI]: 1.03, 2.65). Female sex was strongly associated with higher incidence, up to 3.4 times greater than in males. Obesity (BMI ≥ 30) increased risk, relative risk [RR] of 1.40 (95% CI: 1.08, 1.87), and each 5 kg/m² increase raised risk by 5% (hazard ration [HR] = 1.05; 95% CI: 1.00, 1.10). Height per 10 cm increase was associated with higher risk in both women, HR = 1.38 (95% CI: 1.08, 1.77) and men HR = 1.67 (95% CI: 0.93, 2.97). Occupational exposure to iron was associated with a borderline significant increase in meningioma risk (OR = 1.26; 95% CI: 1.00, 1.58), with a stronger and statistically significant association in women (OR = 1.70; 95% CI: 1.00, 2.89). Additionally, higher occupational exposures to chromium and nickel were linked to an increase in risk, with ORs ranging from 1.2-1.7. Hormonal exposures including chlormadinone acetate (RR = 3.1), cyproterone acetate (RR = 11.4) and fertility treatments (OR = 4.97) were significantly increased risk. Analgesic use was also implicated: aspirin (OR = 1.41) and acetaminophen (OR = 1.85). Brain radiation exposure showed a clear dose-dependent risk increase (excess RR/1 Gy = 1.82), suggesting a strong linear relationship.
CONCLUSIONS: Meningioma risk is influenced by age, gender, BMI, height, hormonal therapies, analgesics, and occupational exposure to metals and radiation, highlighting the complex interplay of biological, environmental, and lifestyle factors.
Conference/Value in Health Info
2025-11, ISPOR Europe 2025, Glasgow, Scotland
Value in Health, Volume 28, Issue S2
Code
EPH132
Topic
Epidemiology & Public Health
Topic Subcategory
Safety & Pharmacoepidemiology
Disease
Neurological Disorders, Oncology